Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis

Receptor for advanced glycation end-products in neurodegenerative diseases

(2015) Judyta Juranek et al.   REVIEWS IN THE NEUROSCIENCES

Soluble RAGEs — Prospects for treating & tracking metabolic and inflammatory disease

(2015) Ann Marie Schmidt   VASCULAR PHARMACOLOGY

Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling

(2015) Fabiola Rojas et al.   Frontiers in Cellular Neuroscience

Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis

(2014) Ashley E. Frakes et al.   NEURON

Microglia centered pathogenesis in ALS: insights in cell interconnectivity

(2014) Dora Brites et al.   Frontiers in Cellular Neuroscience

Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE

(2013) Judyta K. Juranek et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons

(2013) Ali Saleh et al.   EXPERIMENTAL NEUROLOGY

Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond

(2013) Gurdip Daffu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies

(2013) Judyta K. Juranek et al.   Brain and Behavior

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

(2012) Kinnari Sathe et al.   BRAIN

Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer’s disease

(2012) Furu Liang et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

(2012) Christine Vogel et al.   NATURE REVIEWS GENETICS

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

(2012) Peter Teismann et al.   NEUROBIOLOGY OF AGING

Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease

(2011) Serenella Anzilotti et al.   BRAIN RESEARCH BULLETIN

High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products

(2011) Andréy Mazarati et al.   EXPERIMENTAL NEUROLOGY

S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release

(2011) Roberta Bianchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Image Analysis Tools for Evaluation of Microscopic Views of Immunohistochemically Stained Specimen in Medical Research–a Review

(2011) Keerthana Prasad et al.   JOURNAL OF MEDICAL SYSTEMS

HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration

(2011) H.-M. Gao et al.   JOURNAL OF NEUROSCIENCE

The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration

(2011) S.M. Hearst et al.   NEUROSCIENCE

Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue

(2011) M. Casula et al.   NEUROSCIENCE

High-Mobility Group Box 1, Oxidative Stress, and Disease

(2010) Daolin Tang et al.   ANTIOXIDANTS & REDOX SIGNALING

Association of the RAGE G82S polymorphism with Alzheimer’s disease

(2010) Jonny Daborg et al.   JOURNAL OF NEURAL TRANSMISSION

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

(2010) S. D. Sussmuth et al.   NEUROLOGY

Exposure to CSF from sporadic amyotrophic lateral sclerosis patients induces morphological transformation of astroglia and enhances GFAP and S100β expression

(2010) K. Shobha et al.   NEUROSCIENCE LETTERS

Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer’s disease

(2009) Michelle Y. Wang et al.   ACTA NEUROPATHOLOGICA

Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

(2009) Shi Fang Yan et al.   ANNALS OF MEDICINE

RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer’s disease animal model

(2009) H. J. Cho et al.   FASEB JOURNAL

RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease

(2009) Fang Fang et al.   FASEB JOURNAL

Association between the RAGE G82S polymorphism and Alzheimer’s disease

(2009) Keshen Li et al.   JOURNAL OF NEURAL TRANSMISSION

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

(2009) Tony Valente et al.   NEUROBIOLOGY OF DISEASE

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

(2008) J. Iłżecka   ACTA NEUROLOGICA SCANDINAVICA

Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis

(2008) Åsa Andersson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

S100B/RAGE-dependent activation of microglia via NF-κB and AP-1

(2008) Roberta Bianchi et al.   NEUROBIOLOGY OF AGING